메뉴 건너뛰기




Volumn 60, Issue 4, 2001, Pages 319-321

Effects of pravastatin therapy on serum lipids and coronary reactivity are not associated with SREBP cleavage-activating protein polymorphism in healthy young men [3]

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PRAVASTATIN; REGULATOR PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN CLEAVAGE ACTIVATING PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

EID: 0034749244     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2001.600413.x     Document Type: Letter
Times cited : (19)

References (9)
  • 1
    • 0030941803 scopus 로고    scopus 로고
    • The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
    • (1997) Cell , vol.89 , pp. 331-340
    • Brown, M.S.1    Goldstein, J.L.2
  • 5
    • 0032554676 scopus 로고    scopus 로고
    • Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)
    • West of Scotland Coronary Prevention Study Group
    • (1998) Circulation , vol.97 , pp. 1440-1445
  • 7
    • 0032865010 scopus 로고    scopus 로고
    • Mechanisms modifying atherosclerotic disease - From lipids to vascular biology
    • (1999) Atherosclerosis , vol.147 , pp. S3-S10
    • Weissberg, P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.